Hemorrhagic risk in patients who undergo deep brain stimulation on chronic antiplatelet or anticoagulation therapy
PARKINSONISM & RELATED DISORDERS(2023)
Abstract
Background: Deep brain stimulation (DBS) is the main surgical treatment for medically refractory movement disorders. Many patients are older with medical comorbidities necessitating antiplatelet or anticoagulation use. There is limited data on intracranial bleeding or thromboembolic complications surrounding use of chronic antiplatelet or anticoagulation treatment for patients who undergo DBS surgery.
MoreTranslated text
Key words
hemorrhagic risk,chronic antiplatelet,deep brain stimulation
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined